8-[(1S,5R,6S)-6-[2,4-Dihydroxy-3-(3-methyl-2-buten-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-2-cyclohexen-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methyl-2-buten-1-yl)-4H-chromen-4-one(CAS: 76472-87-2)

The compound follows regulatory guidelines such as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations for Europe, and FDA/EPA requirements for handling and labeling. Safe handling, storage, and disposal must adhere to these guidelines to ensure environmental and occupational safety.

There are alternative reagents such as 2,4-dihydroxybenzaldehyde and 2-methyl-2-buten-1-ol that can be used as substitutes in the synthesis of this compound. These alternatives can provide similar functionalities and can be chosen based on cost, availability, and specific chemical requirements.

The market for this compound shows increasing interest in its use as a potential anti-inflammatory agent and antioxidant. Research trends indicate a focus on its pharmacological properties and applications in pharmaceutical and cosmetic industries. However, further studies are needed to validate its efficacy and safety in various therapeutic settings.

Waste containing this compound should be collected, stored, and disposed of according to EPA guidelines and local regulations. Incineration or professional waste disposal services are recommended to ensure safe and environmentally friendly disposal. Proper precautions must be taken to prevent environmental contamination and ensure worker safety during handling and disposal.